Search results for "Flucytosine"

showing 3 items of 3 documents

Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy

2003

Since neural progenitor cells can engraft stably into brain tumors and differentiate along the neuronal and glial line, we tested the hypothesis that transplanted cytosine deaminase (CD)-expressing ST14A cells (an immortalized neural progenitor cell line) can convert locally 5-fluorocytosine (5-FC) into 5-fluorouracil (5-FU) and produce a regression of glioma tumors. ST14A, retrovirally transduced with the E. coli CD gene, showed a strong bystander effect on glioma cells as assessed by in vitro assay. Intracerebral injection of C6 glioma cells generated a rapidly growing tumoral mass. DiI prelabeled ST14A, coinjected into the rat brain with C6 glioma cells, survived in the tumoral mass up t…

Cancer ResearchPathologymedicine.medical_specialtyGenetic enhancementBrain tumorFlucytosineBiologyTransfectionCytosine DeaminaseRats Sprague-DawleyGliomamedicineEscherichia coliAnimalsProdrugsProgenitor cellMolecular BiologyCells CulturedNeuronsBrain NeoplasmsStem CellsCytosine deaminaseTransfectionGenetic TherapyGliomamedicine.diseaseNeural stem cellRatsTransplantationMolecular MedicineFluorouracilStem Cell Transplantation
researchProduct

Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum

1994

This study addressed the effects of fluconazole and 5-fluorocytosine on the candidacidal activity of amphotericin B in the presence of human serum. A Candida albicans isolate that was susceptible to all three agents according to standard testing procedures was employed. Fungicidal activity was estimated by using a flow cytometric procedure that exploited the fact that yeast cells killed by amphotericin B diminish in size and take up propidium iodide. The following findings were made. (i) Fluconazole and 5-fluorocytosine each failed to inhibit pseudohyphal formation and cell aggregation even when applied at 10 and 50 micrograms/ml, respectively, for up to 10 h. Hence, these agents were not f…

FlucytosinePharmacologyFlucytosineMicrobiologychemistry.chemical_compoundAmphotericin BAmphotericin BCandida albicansmedicineHumansPharmacology (medical)Propidium iodideCandida albicansFluconazolePharmacologybiologyDrug interactionBlood Physiological PhenomenaFlow Cytometrybiology.organism_classificationCell aggregationIn vitroInfectious DiseaseschemistryFluconazoleResearch Articlemedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Combination therapy in a model of pulmonary aspergillosis

2009

Summary. The current treatment for pulmonary aspergillosis, amphotericin B, is toxic and not always effective. This study was done to evaluate combinations of amphotericin B with other agents in an animal model of pulmonary aspergillosis. Sprague-Dawley rats were treated with cortisone acetate, infected intratracheally with 106 spores of Aspergillus fumigatus, and followed daily for survival. Mortality among controls started on day 2, and it was 80% by day seven, whereas therapy with amphotericin B resulted in survival of all animals. When given alone, ketoconazole, 5-fluorocytosine and rifampin did not improve survival. The combination of ketoconazole with amphotericin B resulted in comple…

biologyCombination therapyItraconazolebusiness.industryDermatologyGeneral MedicinePharmacologybiology.organism_classificationAspergillosismedicine.diseaseAspergillus fumigatusFlucytosineInfectious DiseasesAmphotericin BImmunologymedicineKetoconazolebusinessMycosismedicine.drugMycoses
researchProduct